Bifogade filer
Kurs
+0,88%
Likviditet
27,7 MDKK
Kalender
Est. tid* | ||
2025-11-13 | 07:00 | Kvartalsrapport 2025-Q3 |
2025-08-14 | 07:00 | Kvartalsrapport 2025-Q2 |
2025-05-08 | - | Kvartalsrapport 2025-Q1 |
2025-03-28 | - | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2025-03-27 | - | Årsstämma |
2025-02-20 | - | Bokslutskommuniké 2024 |
2024-11-07 | - | Kvartalsrapport 2024-Q3 |
2024-08-15 | - | Kvartalsrapport 2024-Q2 |
2024-05-16 | - | Kvartalsrapport 2024-Q1 |
2024-03-21 | - | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2024-03-20 | - | Årsstämma |
2024-02-27 | - | Bokslutskommuniké 2023 |
2023-11-09 | - | Kvartalsrapport 2023-Q3 |
2023-08-17 | - | Kvartalsrapport 2023-Q2 |
2023-05-11 | - | Kvartalsrapport 2023-Q1 |
2023-03-30 | - | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2023-03-29 | - | Årsstämma |
2023-03-02 | - | Bokslutskommuniké 2022 |
2022-11-10 | - | Kvartalsrapport 2022-Q3 |
2022-08-11 | - | Kvartalsrapport 2022-Q2 |
2022-05-12 | - | Kvartalsrapport 2022-Q1 |
2022-05-09 | - | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2022-04-06 | - | Årsstämma |
2022-03-10 | - | Bokslutskommuniké 2021 |
2021-11-11 | - | Kvartalsrapport 2021-Q3 |
2021-08-12 | - | Kvartalsrapport 2021-Q2 |
2021-05-12 | - | Kvartalsrapport 2021-Q1 |
2021-04-16 | - | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2021-04-15 | - | Årsstämma |
2021-03-11 | - | Bokslutskommuniké 2020 |
2020-11-12 | - | Kvartalsrapport 2020-Q3 |
2020-08-13 | - | Kvartalsrapport 2020-Q2 |
2020-05-14 | - | Kvartalsrapport 2020-Q1 |
2020-04-03 | - | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2020-04-02 | - | Årsstämma |
2020-03-12 | - | Bokslutskommuniké 2019 |
2019-11-14 | - | Kvartalsrapport 2019-Q3 |
2019-08-15 | - | Kvartalsrapport 2019-Q2 |
2019-05-16 | - | Kvartalsrapport 2019-Q1 |
2019-04-05 | - | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2019-04-04 | - | Årsstämma |
2019-03-07 | - | Bokslutskommuniké 2018 |
2018-11-15 | - | Kvartalsrapport 2018-Q3 |
2018-08-16 | - | Kvartalsrapport 2018-Q2 |
2018-05-16 | - | Kvartalsrapport 2018-Q1 |
2018-04-20 | - | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2018-04-19 | - | Årsstämma |
2018-03-07 | - | Bokslutskommuniké 2017 |
2017-11-08 | - | Kvartalsrapport 2017-Q3 |
2017-08-24 | - | Kvartalsrapport 2017-Q2 |
2017-05-17 | - | Kvartalsrapport 2017-Q1 |
2017-04-06 | - | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2017-04-05 | - | Årsstämma |
2017-03-15 | - | Bokslutskommuniké 2016 |
2016-11-09 | - | Kvartalsrapport 2016-Q3 |
2016-08-25 | - | Kvartalsrapport 2016-Q2 |
2016-05-18 | - | Kvartalsrapport 2016-Q1 |
2016-04-20 | - | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2016-04-19 | - | Årsstämma |
2016-03-16 | - | Bokslutskommuniké 2015 |
2015-11-05 | - | Kvartalsrapport 2015-Q3 |
2015-08-28 | - | Kvartalsrapport 2015-Q2 |
2015-05-22 | - | Kvartalsrapport 2015-Q1 |
2015-04-22 | - | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2015-04-21 | - | Årsstämma |
2015-03-12 | - | Bokslutskommuniké 2014 |
2014-11-07 | - | Kvartalsrapport 2014-Q3 |
2014-08-21 | - | Kvartalsrapport 2014-Q2 |
2014-05-06 | - | Kapitalmarknadsdag 2014 |
2014-04-29 | - | Årsstämma |
2014-04-29 | - | Kvartalsrapport 2014-Q1 |
2014-03-21 | - | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2014-03-20 | - | Bokslutskommuniké 2013 |
2013-11-15 | - | Kvartalsrapport 2013-Q3 |
2013-08-29 | - | Kvartalsrapport 2013-Q2 |
2013-05-15 | - | Kvartalsrapport 2013-Q1 |
2013-04-30 | - | Årsstämma |
2013-04-30 | - | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2013-03-14 | - | Bokslutskommuniké 2012 |
2012-11-29 | - | Kapitalmarknadsdag 2012 |
2012-04-26 | - | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2012-04-25 | - | Årsstämma |
2011-11-17 | - | Kvartalsrapport 2011-Q3 |
2011-10-25 | - | Kapitalmarknadsdag 2011 |
2011-08-18 | - | Kvartalsrapport 2011-Q2 |
2011-05-12 | - | Kvartalsrapport 2011-Q1 |
2011-04-29 | - | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2011-04-28 | - | Årsstämma |
Beskrivning
Land | Danmark |
---|---|
Lista | Large Cap Copenhagen |
Sektor | Hälsovård |
Industri | Bioteknik |
Company announcement – No. 33 / 2019
Zealand Pharma completes subscription of new shares and registration of capital increase
Copenhagen, September 11, 2019 – With reference to the company announcement no. 30/2019 dated September 5, 2019 regarding a private placement and directed issue of 3,975,000 new ordinary shares of the company (the "New Shares"), Zealand Pharma A/S ("Zealand") announces that it has today increased its share capital by DKK 3,975,000, divided into 3,975,000 New Shares with a nominal value of DKK 1 each. The gross proceeds from the issuance of the New Shares amounts to DKK 559.6 million.
Following the registration of the New Shares with the Danish Business Authority, Zealand's share capital amounts to DKK 35,806,290 divided into 35,806,290 shares with a nominal value of DKK 1 each.
The New Shares rank pari passu with Zealand's existing shares and carry the same dividend and other rights. Each New Share carries one vote at Zealand's general meetings. Zealand only has one class of shares.
The New Shares have been issued today and are expected to be admitted to trading on Nasdaq Copenhagen on September 12, 2019 in Zealand's permanent ISIN code DK0060257814.
The amendments to Zealand's articles of association required by the capital increase have been registered today with the Danish Business Authority.
For further information, please contact:
Emmanuel Dulac, President and Chief Executive Officer
Tel.: +45 50 60 36 36, e-mail: edu@zealandpharma.com
Lani Pollworth Morvan, Investor Relations and Communication
Tel.: +45 50 60 37 78, e-mail: lpm@zealandpharma.com
About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq Copenhagen and New York: ZEAL) ("Zealand") is a biotechnology company focused on the discovery and development of innovative peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market. Zealand’s current pipeline of internal product candidates focus on specialty gastrointestinal and metabolic diseases. Zealand’s portfolio also includes two clinical license collaborations with Boehringer Ingelheim and pre-clinical license collaboration with Alexion Pharmaceuticals.
Zealand is based in Copenhagen (Søborg), Denmark. For further information about the Company's business and activities, please visit www.zealandpharma.com or follow Zealand on LinkedIn or Twitter @ZealandPharma.
Attachment